Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett P Monia

Showing results (31-40 of 147) with videos related to

Pageof 15
Sort By:
Molecular Cancer Therapeutics|February 27, 2004
Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effectRichard L Hayward, Janet S Macpherson, Jeff Cummings, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 17, 2008
Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expressionXing Xian Yu, Sanjay K Pandey, Sheri L Booten, et al.
Nature Communications|April 29, 2022
CFTR mRNAs with nonsense codons are degraded by the SMG6-mediated endonucleolytic decay pathwayEdward J Sanderlin, Melissa M Keenan, Martin Mense, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 5, 2008
Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese miceXing Xian Yu, Susan F Murray, Lynnetta Watts, et al.
Oncogene|August 1, 2002
PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cellsYong Choi, Jie Zhang, Cristina Murga, et al.
The Journal of Clinical Investigation|May 3, 2005
Severe impairment in liver insulin signaling fails to alter hepatic insulin action in conscious miceChristoph Buettner, Rima Patel, Evan D Muse, et al.
Plos One|August 8, 2013
Peripheral reduction of FGFR4 with antisense oligonucleotides increases metabolic rate and lowers adiposity in diet-induced obese miceXing Xian Yu, Lynnetta M Watts, Vara Prasad Manchem, et al.
Melanoma Research|September 24, 2005
Effect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluorouracil on the viability of melanoma cell linesCharles S Smith, Vita M Golubovskaya, Erin Peck, et al.
Genome Biology|January 17, 2018
Antisense suppression of the nonsense mediated decay factor Upf3b as a potential treatment for diseases caused by nonsense mutationsLulu Huang, Audrey Low, Sagar S Damle, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 14, 2010
Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatmentMerrill D Benson, Richard A Smith, Gene Hung, et al.
Pageof 15

Showing results (31-40 of 147) with videos related to

Sort By:
Pageof 15
Molecular Cancer Therapeutics|February 27, 2004
Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effectRichard L Hayward, Janet S Macpherson, Jeff Cummings, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 17, 2008
Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expressionXing Xian Yu, Sanjay K Pandey, Sheri L Booten, et al.
Nature Communications|April 29, 2022
CFTR mRNAs with nonsense codons are degraded by the SMG6-mediated endonucleolytic decay pathwayEdward J Sanderlin, Melissa M Keenan, Martin Mense, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 5, 2008
Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese miceXing Xian Yu, Susan F Murray, Lynnetta Watts, et al.
Oncogene|August 1, 2002
PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cellsYong Choi, Jie Zhang, Cristina Murga, et al.
The Journal of Clinical Investigation|May 3, 2005
Severe impairment in liver insulin signaling fails to alter hepatic insulin action in conscious miceChristoph Buettner, Rima Patel, Evan D Muse, et al.
Plos One|August 8, 2013
Peripheral reduction of FGFR4 with antisense oligonucleotides increases metabolic rate and lowers adiposity in diet-induced obese miceXing Xian Yu, Lynnetta M Watts, Vara Prasad Manchem, et al.
Melanoma Research|September 24, 2005
Effect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluorouracil on the viability of melanoma cell linesCharles S Smith, Vita M Golubovskaya, Erin Peck, et al.
Genome Biology|January 17, 2018
Antisense suppression of the nonsense mediated decay factor Upf3b as a potential treatment for diseases caused by nonsense mutationsLulu Huang, Audrey Low, Sagar S Damle, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 14, 2010
Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatmentMerrill D Benson, Richard A Smith, Gene Hung, et al.
Pageof 15